论文信息 - Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis

Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis

Vancomycin pharmacokinetics were studied in four patients with peritonitis undergoing chronic intermittent peritoneal dialysis. Serum levels exceeding 4.0 micrograms/ml were maintained for 8 and 13 days after a single 1-g intravenous dose. Vancomycin serum concentrations measured before, during, and upon completion of dialysis revealed no appreciable decline. Peritoneal fluid concentrations in two patients exceeded 4.0 micrograms/ml for more than 12 days.

S. Rosansky | B. Postic | B. Magera | J. Arroyo

[1] D. Krogstad,et al. Single‐Dose Kinetics of Intravenous Vancomycin , 1980, Journal of clinical pharmacology.

[2] J. Rotschafer,et al. Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations , 1980, Antimicrobial Agents and Chemotherapy.

[3] J. F. Aruffo,et al. Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis , 1979, Antimicrobial Agents and Chemotherapy.

[4] N. Benowitz,et al. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. , 1979, Clinical nephrology.

[5] R. Gleckman,et al. Vancomycin. A second look. , 1977, JAMA.

[6] A. Morris,et al. Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. , 1971, The American journal of the medical sciences.

[7] G. Mccracken,et al. Clinical pharmacology and efficacy of vancomycin in pediatric patients. , 1980, The Journal of pediatrics.

[8] H. E. Hansen,et al. Peritoneal transport of vancomycin during peritoneal dialysis. , 1979, Nephron.

[9] W. Farrar,et al. ‘VANCOMYCIN REVISITED’ , 1978, Annals of internal medicine.